ATE173014T1 - Afamin: ein menschliches serum albumin ähnliches protein - Google Patents

Afamin: ein menschliches serum albumin ähnliches protein

Info

Publication number
ATE173014T1
ATE173014T1 AT95915503T AT95915503T ATE173014T1 AT E173014 T1 ATE173014 T1 AT E173014T1 AT 95915503 T AT95915503 T AT 95915503T AT 95915503 T AT95915503 T AT 95915503T AT E173014 T1 ATE173014 T1 AT E173014T1
Authority
AT
Austria
Prior art keywords
human serum
protein
serum albumin
afamin
human
Prior art date
Application number
AT95915503T
Other languages
English (en)
Inventor
Henri Stephen Lichenstein
David Edwin Lyons
Mark Matsuo Wurfel
Samuel Donald Wright
Original Assignee
Amgen Inc
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Univ Rockefeller filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE173014T1 publication Critical patent/ATE173014T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95915503T 1994-03-31 1995-03-31 Afamin: ein menschliches serum albumin ähnliches protein ATE173014T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/222,619 US5652352A (en) 1994-03-31 1994-03-31 Afamin: a human serum albumin-like gene

Publications (1)

Publication Number Publication Date
ATE173014T1 true ATE173014T1 (de) 1998-11-15

Family

ID=22832990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95915503T ATE173014T1 (de) 1994-03-31 1995-03-31 Afamin: ein menschliches serum albumin ähnliches protein

Country Status (11)

Country Link
US (2) US5652352A (de)
EP (1) EP0754229B1 (de)
JP (1) JPH09511399A (de)
AT (1) ATE173014T1 (de)
AU (1) AU691607B2 (de)
CA (1) CA2186516A1 (de)
DE (1) DE69505804T2 (de)
DK (1) DK0754229T3 (de)
ES (1) ES2123973T3 (de)
MX (1) MX9604402A (de)
WO (1) WO1995027059A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410269B1 (en) * 1995-06-07 2002-06-25 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
US20060014143A1 (en) * 1995-06-07 2006-01-19 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
US7208576B2 (en) * 1999-01-06 2007-04-24 Merrimack Pharmaceuticals, Inc. Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
AT407675B (de) * 1999-06-25 2001-05-25 Vita Tech Illmensee Dieplinger Verfahren zur fertilitätsbestimmung von säugetieren, insbesondere von menschen
EP1377306A1 (de) * 2001-03-09 2004-01-07 Dyax Corp. Serumalbumin-bindende anteile
AT411014B (de) * 2001-04-30 2003-09-25 Vitateq Biotechnology Gmbh Präparationen von vitamin e in kombination mit afamin
PT1463751E (pt) 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
US20040009534A1 (en) * 2002-06-14 2004-01-15 Dyax Corporation Protein analysis
JP4492156B2 (ja) * 2004-03-03 2010-06-30 ニプロ株式会社 血清アルブミンドメインを含む蛋白質
AT501348B1 (de) * 2005-01-31 2008-10-15 Vitateq Biotechnology Gmbh Verfahren zur tumordiagnose
EP2035830B1 (de) * 2006-06-14 2015-03-25 Johns Hopkins University Albumingebundener protein-/peptidkomplex als biomarker für erkrankungen
AT505727B1 (de) * 2007-09-04 2009-06-15 Univ Innsbruck Verfahren zur diagnose des metabolischen syndroms
WO2013000992A1 (en) 2011-06-28 2013-01-03 Vitateq Biotechnology Gmbh Method for diagnosing preeclampsia
GB2511525A (en) * 2013-03-05 2014-09-10 Randox Teoranta Methods and Compositions for the Diagnosis of Alzheimer's Disease
JP2016188761A (ja) * 2013-08-23 2016-11-04 国立研究開発法人国立国際医療研究センター 糖尿病腎症の発症または発症リスクの検出方法及びキット
EP3037824A1 (de) 2014-12-22 2016-06-29 Vitateq Biotechnology GmbH Verfahren zur Detektion und/oder Quantifizierung von Afamin
EP3581584B1 (de) 2014-12-24 2022-03-30 Osaka University Verfahren zur herstellung von wnt-protein und verfahren zur lagerung von wnt-protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1226551B (it) * 1988-07-29 1991-01-24 Sclavo Spa Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
US6268212B1 (en) * 1993-10-18 2001-07-31 Amgen Inc. Tissue specific transgene expression

Also Published As

Publication number Publication date
DK0754229T3 (da) 1999-07-19
EP0754229A1 (de) 1997-01-22
DE69505804T2 (de) 1999-07-08
ES2123973T3 (es) 1999-01-16
JPH09511399A (ja) 1997-11-18
CA2186516A1 (en) 1995-10-12
US5767243A (en) 1998-06-16
AU691607B2 (en) 1998-05-21
MX9604402A (es) 1997-07-31
US5652352A (en) 1997-07-29
AU2236795A (en) 1995-10-23
EP0754229B1 (de) 1998-11-04
WO1995027059A1 (en) 1995-10-12
DE69505804D1 (de) 1998-12-10

Similar Documents

Publication Publication Date Title
DE69505804D1 (de) Afamin: ein menschliches serum albumin ähnliches protein
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
DE69131580D1 (de) GDF-1 und UOG1 Proteine
ATE389666T1 (de) Hohe expressionsrate von proteinen
DK0807178T3 (da) Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose
AU8747791A (en) Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
DE69634077D1 (de) Haemophilus adhäsionsproteinen
MX9602557A (es) Proteinas de higado de mamifero y su uso en oncologia.
DE69524971T2 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
ATE139541T1 (de) Kollagen-bindendes protein sowie dessen herstellung
SE9602822D0 (sv) New receptor
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
WO1996016170A3 (en) Proteins involved in the regulation of cell-cell adhesion and uses thereof
WO1992011367A3 (en) Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
CA2199843A1 (en) Novel PKA-Binding Proteins and Uses Thereof
ATE315646T1 (de) Leukocyten-aktivierender faktor
NZ503256A (en) Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding protein receptors
SE9604439D0 (sv) New receptor
WO2001018194A3 (en) Maize casein kinase 1 orthologue and uses thereof
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification